Intriguingly, the heterogeneous nuclear ribonucleoprotein A2/B1 (HNRNPA2/B1) was demonstrated to be increased in endocrine-resistant LCC9 breast cancer cells and modulating the miRNA transcriptome upon its overexpression in MCF-7 cells [188]. This evidence concerns the gene HNRNPA2B1 and breast cancer.